K162868
K162868
K162868
__________________________________________________________________________________________________________________________
Re: K162868
Trade/Device Name: Exam Vue PACS
Regulation Number: 21 CFR 892.2050
Regulation Name: Picture archiving and communications system
Regulatory Class: II
Product Code: LLZ
Dated: March 3, 2017
Received: March 7, 2017
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability
warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA),
it may be subject to additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Page 2— Mr. William Little
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041
or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note
the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the
Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301)
796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
For
Robert Ochs, Ph.D.
Director
Division of Radiological Health
Office of In Vitro Diagnostics
and Radiological Health
Center for Devices and Radiological Health
Enclosure
DEPARTMENT OF HEALTH AND HUMAN SERVICES Form Approved: OMB No. 0910-0120
Food and Drug Administration Expiration Date: January 31, 2017
Indications for Use See PRA Statement below.
Device Name
ExamVue PACS
The software is a software package used with general purpose computing hardware to receive, store, distribute, process
and display images and associated data throughout a clinical environment. The software performs digital image
processing, measurement, communication and storage. This device is not indicated for use in mammography.
ExamVue PACS supports receiving, sending, printing, storing and displaying studies received from the following
modality types via DICOM: CR and DX.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number.”
FORM FDA 3881 (8/14) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF
510 (k) Summary
February 28th, 2017.
2. Identification of Device
3. Predicate Device
Manufacturer: Televere
Device: Tigerview Professional
510(k) Number: K061035
Classification Name: Imaging Processing System, Radiological
Common Name: Picture Archiving and Communication System (PACS)
Regulatory Number: 21 CFR 892.2050
Regulatory Class: II
Product Code: 90 LLZ
1
4. Product Classification Names and Citations
5. Description:
The ExamVue PACS is a software solution for the storage, sharing, display and
viewing for diagnosis of medical images. It consists of two software components, a
central database and server software that holds, receives and distributes images,
and a viewer program that can be installed on multiple computers for viewing,
modifying, making measurements on, and displaying the images in the database.
The software is a software package used with general purpose computing hardware
to receive, store, distribute, process and display images and associated data
throughout a clinical environment. The software performs digital image processing,
measurement, communication and storage. This device is not indicated for use in
mammography.
JPI Healthcare Co., Ltd, believes that the ExamVue PACS is substantially
equivalent to the predicate devices, TigerView Professional and QXLink
All three devices have the same basic structure (a central server database and
associated viewers), function (the storage, display and diagnosis of DICOM
images) and follow the DICOM protocol. They have similar intended uses, and
provide similar suites of tools to fulfil their function.
The ExamVue PACS differs from the predicate devices is user interface and
compatible operating systems. We believe this does not represent a substantial
difference between the two devices, as the change in system requirements reflect
the change in computer technology since the release of the predicate device, and
the user interface presents the same essential data and supports similar workflow
as the predicate device.
2
8. Safety, EMC and Performance Data
Safety testing and documentation was performed in accordance with IEEE 1012-
2012, Standard for System and Software Verification and Validation.
9. Conclusions:
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807
and based on the information provided in this premarket notification JPI
Healthcare Co., Ltd. concludes that ExamVue PACS is safe and effective and
substantially equivalent to predicate devices as described herein.
3
EXHIBIT 1
ExamVue PACS
supports receiving,
sending, printing,
4
storing and
displaying studies
received from the
following modality
types via DICOM:
CR and DX.
The intended use and environment of the device is the same as the predicate devices, with
only minor differences in features that are not integral to the function of the device. For
this reason, we believe it is substantially equivalent to the predicate devices.